How is age-related macular degeneration diagnosed? Which patient is at risk of the disease? What are the treatment options? These, in short, are the questions to which some of the most authoritative have been asked to answerspecialists in ophthalmology, during the webinar recently held within the training course of Floretina 2021, on the topic ‘Neovascular Amd in real life’, chaired by Edoardo Midena, professor of Diseases of the visual apparatus and director of the School of Specialization in Ophthalmology of the University of Padua, and by Stanislao Rizzo, director of the Ophthalmology complex operating unit of the A. Gemelli Irccs University Hospital of Rome, organized with the unconditional contribution of Bayer.
Read Also
- Men and women: Gemma Galgani rejected by everyone? Sep 6, 2021
- They set a hearing for the Valentina González case: lawyer asks to formalize 2 people and decree roots Nov 10, 2022
- De Meo and Renault’s tomorrow: ” The car of the future will make young people fall in love ” – Video Gaz Sep 15, 2021
- Clermont-Ferrand: A homeless man suspected of having abused children on a merry-go-round Nov 15, 2022
- Meghan Markle, victim of miscarriage, wants to break a “taboo” Nov 25, 2020
- Garamendi sees “difficult” to reach an agreement on the extension of the ERTE before Tuesday Sep 24, 2021
- Dismembered man near Rouen: The two accused sentenced to 22 and 17 years in prison Nov 19, 2022